Table 2. Clinical features of 18... | American Society of Hematology

Table 2.

Clinical features of 18 patients with LONIPCs

				GVHD					Days from SCT to LONIPCs	PFTs at onset of LONIPCs			PFTs after treatment						Mo of survival from LONIPCs
Case no.	LONIPC category	Primary disease	TBI/TLI	Acute	Chronic	Sicca		FVC% predicted	Days from SCT to LONIPCs	FEV1/FVC	FVC% predicted	FEV1/FVC	Pattern of PFTs	Treatment outcome	HOT	Causes of death		Alive or dead	Mo of survival from LONIPCs
1	BO	AML	−	2	E	+	185	91.3	69.6	96.9	72.2	O	PR	−	NA	25.5	Alive
2	BO	AML	−	0	E	+	115	84.2	69.5	84.6	65.3	O	NC	−	NA	74.8	Alive
3	BO	CML	−	2	E	+	150	83.8	66.9	ND	ND	O	P	−	Respiratory failure	4.2	Dead
4	BO	MDS	−	2	E	+	336	87.3	71.8	83.5	67.1	O	P	−	P carinii pneumonia	5.1	Dead
5	BO	AML	+	2	E	+	94	105.9	74.5	59.7	35.4	O	P	+	Relapse	6.3	Dead
6	BO	ALL	+	1	E	+	240	114.1	56.9	101.8	41.3	O	P	+	NA	38.8	Alive
7	IP	NHL	−	0	E	−	180	120.2	78.3	116.3	81.1	N	CR	−	NA	20.4	Alive
8	IP	NHL	+	2	O	+	204	121.9	88.0	111.1	84.5	N	CR	−	NA	24.5	Alive
9	IP	MDS	−	1	E	+	1105	100.7	90.2	111.4	90.0	N	CR	−	NA	15.9	Alive
10	IP	ALL	+	0	O	−	117	111.8	87.5	117.1	82.3	N	CR	−	NA	44.5	Alive
11	IP	AA	+	3	E	+	140	112.2	83.4	126.2	82.8	N	CR	−	NA	52.3	Alive
12	IP	NHL	+	0	E	+	91	96.9	92.3	ND	ND	N	P	−	Respiratory failure	1.1	Dead
13	IP	NHL	+	2	E	+	200	124.8	81.0	ND	ND	N	P	−	Respiratory failure	3.1	Dead
14	IP	NHL	+	1	E	+	300	54.5	96.4	30.4	97.8	R	P	+	NA	45.8	Alive
15	IP/BO ^*	AML	−	0	E	+	540	53.1	57.1	80.3	69.1	M→O	CR	−	NA	44.0	Alive
16	IP	AML	+	1	L	+	144	59.6	77.9	ND	ND	R	CR	−	2nd malignancy (MDS)	27.4	Dead
17	IP	ALL	+	2	E	−	153	65.7	79.9	ND	ND	R	P	−	Respiratory failure	1.5	Dead
18	IP	AML	+	1	E	+	160	57.4	98.7	57.2	99.0	R	P	+	Respiratory failure	45.7	Dead

				GVHD					Days from SCT to LONIPCs	PFTs at onset of LONIPCs			PFTs after treatment						Mo of survival from LONIPCs
Case no.	LONIPC category	Primary disease	TBI/TLI	Acute	Chronic	Sicca		FVC% predicted	Days from SCT to LONIPCs	FEV1/FVC	FVC% predicted	FEV1/FVC	Pattern of PFTs	Treatment outcome	HOT	Causes of death		Alive or dead	Mo of survival from LONIPCs
1	BO	AML	−	2	E	+	185	91.3	69.6	96.9	72.2	O	PR	−	NA	25.5	Alive
2	BO	AML	−	0	E	+	115	84.2	69.5	84.6	65.3	O	NC	−	NA	74.8	Alive
3	BO	CML	−	2	E	+	150	83.8	66.9	ND	ND	O	P	−	Respiratory failure	4.2	Dead
4	BO	MDS	−	2	E	+	336	87.3	71.8	83.5	67.1	O	P	−	P carinii pneumonia	5.1	Dead
5	BO	AML	+	2	E	+	94	105.9	74.5	59.7	35.4	O	P	+	Relapse	6.3	Dead
6	BO	ALL	+	1	E	+	240	114.1	56.9	101.8	41.3	O	P	+	NA	38.8	Alive
7	IP	NHL	−	0	E	−	180	120.2	78.3	116.3	81.1	N	CR	−	NA	20.4	Alive
8	IP	NHL	+	2	O	+	204	121.9	88.0	111.1	84.5	N	CR	−	NA	24.5	Alive
9	IP	MDS	−	1	E	+	1105	100.7	90.2	111.4	90.0	N	CR	−	NA	15.9	Alive
10	IP	ALL	+	0	O	−	117	111.8	87.5	117.1	82.3	N	CR	−	NA	44.5	Alive
11	IP	AA	+	3	E	+	140	112.2	83.4	126.2	82.8	N	CR	−	NA	52.3	Alive
12	IP	NHL	+	0	E	+	91	96.9	92.3	ND	ND	N	P	−	Respiratory failure	1.1	Dead
13	IP	NHL	+	2	E	+	200	124.8	81.0	ND	ND	N	P	−	Respiratory failure	3.1	Dead
14	IP	NHL	+	1	E	+	300	54.5	96.4	30.4	97.8	R	P	+	NA	45.8	Alive
15	IP/BO ^*	AML	−	0	E	+	540	53.1	57.1	80.3	69.1	M→O	CR	−	NA	44.0	Alive
16	IP	AML	+	1	L	+	144	59.6	77.9	ND	ND	R	CR	−	2nd malignancy (MDS)	27.4	Dead
17	IP	ALL	+	2	E	−	153	65.7	79.9	ND	ND	R	P	−	Respiratory failure	1.5	Dead
18	IP	AML	+	1	E	+	160	57.4	98.7	57.2	99.0	R	P	+	Respiratory failure	45.7	Dead

HOT indicates home oxygen therapy; E, extensive type; O, obstructive; PR, partial remission; NC, no change; P, progressive; N, normal; CR, complete remission; R, restrictive; M, mixed; L, limited type; NA, not applicable; and ND, not done.

Case 15: BO was diagnosed after the improvement of IP.

View Large

This Feature Is Available To Subscribers Only